Effect of pentoxifylline on multiple sclerosis treatment
Not Applicable
- Conditions
- MULTIPLE SCLEROSIS.Multiple sclerosis
- Registration Number
- IRCT201301148430N7
- Lead Sponsor
- euroscience Research center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
inclusion criteria:
new case of MS compatible with MC donalds ?relapsing -remitting pattern ? age between 20-40 Y/O
exclusion criteria:
other patterns of MS except RRMS? other immunomodulatory medications use except beta interferon?pregnancy and lactation ?concurrent autoimmune diseases and it's related drugs?allergy to drug ?liver disease?renal disease ?antihypertensive and ASA and anticoagolant drugs
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence. Timepoint: monthly. Method of measurement: clinical examination.;Expanded Disability Status Scale. Timepoint: before of the treatment, 6 months after and at the end of the treatment. Method of measurement: clinical examination.
- Secondary Outcome Measures
Name Time Method